Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.61 |
| ▸ | DRD2 | P14416 | 1/20 | 0.57 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.54 |
| ▸ | HTR1D | P28221 | 2/20 | 0.49 |
| ▸ | HTR1B | P28222 | 2/20 | 0.49 |
| ▸ | MCOLN2 | Q8IZK6 | 1/20 | 0.48 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.48 |
| ▸ | MCOLN1 | Q9GZU1 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4736528 | 1.00 | HTR2C (0.68) | HTR2CMEN1KMT2ADRD2PTGDR2 | |
| SCHEMBL30938438 | 1.00 | HTR2C (0.68) | HTR2CMEN1KMT2ADRD2PTGDR2 | |
| SCHEMBL1428861 | 1.00 | HTR2C (0.68) | HTR2CMEN1KMT2ADRD2PTGDR2 | |
| SCHEMBL7545433 | 0.98 | HTR2C (0.70) | HTR2CMEN1KMT2ADRD2PTGDR2 | |
| SCHEMBL29965845 | 0.94 | HTR2C (0.70) | HTR2CMEN1KMT2ADRD2ATM | |
| SCHEMBL19291072 | 0.94 | HTR2C (0.70) | HTR2CMEN1KMT2ADRD2ATM | |
| SCHEMBL1515163 | 0.90 | HTR2C (0.75) | HTR2CMEN1KMT2ADRD2ATM | |
| SCHEMBL21471522 | 0.85 | MEN1 (0.52) | HTR2CMEN1KMT2ADRD2PTGDR2 | |
| SCHEMBL12897136 | 0.84 | MEN1 (0.61) | HTR2CMEN1KMT2ADRD2MCOLN2 | |
| SCHEMBL12896742 | 0.84 | MEN1 (0.61) | HTR2CMEN1KMT2ADRD2MCOLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101522710-A | CD4 mimic peptides and their uses | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2009-09-02 | — | — | CN | claimed |
| US-5475155-A | Reacting an alpha-haloketone with a phenolic-hydroxyl containing compound and a strong protonic acid; neutralization; dehydrohalogenation; dealkylation | THE DOW CHEMICAL COMPANY (US) | 1995-12-12 | — | — | US | claimed |
| WO-1995015301-A1 | PREPARATION OF 4,4'-DIHYDROXY-ALPHA-ALKYLSTILBENES AND 4,4'-DIHYDROXY-ALPHA, ALPHA'-DIALKYLSTILBENES | THE DOW CHEMICAL COMPANY (US) | 1995-06-08 | — | — | WO | claimed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | claimed |
| US-11344511-B2 | Compounds and methods of promoting myelination | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-05-31 | — | — | US | disclosed |
| EP-2694437-B1 | PROCESS FOR PRODUCING ACYLATION CATALYST | BASF SE (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20190269670-A1 | COMPOUNDS AND METHODS OF PROMOTING MYELINATION | CASE WESTERN RESERVE UNIVERSITY | 2019-09-05 | — | — | US | disclosed |
| CN-107815321-A | The preparation method of lateral o-difluoro-benzene class liquid-crystal compounds containing cyclohexyl | 晶美晟光电材料（南京）有限公司 | 2018-03-20 | — | — | CN | disclosed |
| US-20170349607-A1 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | NUEVOLUTION A/S (DK) | 2017-12-07 | — | — | US | disclosed |
| US-9815843-B2 | Compound, photosensitive resin composition comprising the same, and color filter | SAMSUNG SDI CO., LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9815843-B2 | Compound, photosensitive resin composition comprising the same, and color filter | SAMSUNG SDI CO., LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-20170107224-A1 | Novel Compound, Photosensitive Resin Composition Comprising the Same, and Color Filter | SAMSUNG SDI CO., LTD. (KR) | 2017-04-20 | — | — | US | disclosed |
| US-5284971-A | No cardiac side effects | SYNTEX (U.S.A.) INC. (US) | 1994-02-08 | — | — | US | disclosed |
| US-4837301-A | FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| EP-0275007-A2 | Process for the preparation of highly molecular, optionally branched polyarylene sulfides | BAYER AG (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4632987-A | FORMYLATION, HYDROLYSIS, CONDENSATION OF BENZENE AND NAPHTHALENE COMPOUNDS | MITSUI TOATSU CHEMICALS INCORPORATED (JP) | 1986-12-30 | — | — | US | disclosed |
| EP-0076220-B1 | PROCESS FOR THE HYDROLYSIS OF ARYL ALIPHATIC ETHERS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1985-08-07 | — | — | EP | disclosed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | disclosed |
| US-4435397-A | ADRENERGIC BLOCKING AGENTS, 4-(3-ARYLOXY-2-HYDROXYPROPYL) SUBSTITUTED | NIPPON SHINYAKU CO., LTD. (JP) | 1984-03-06 | — | — | US | disclosed |
| EP-0076220-A1 | Process for the hydrolysis of aryl aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170107224-A1 | Novel Compound, Photosensitive Resin Composition Comprising the Same, and Color Filter | RB1, SUN2, ASIC1 | HTR2C 3511/4885MEN1 2184/4885KMT2A 440/4885 |
| US-11344511-B2 | Compounds and methods of promoting myelination | GMFG, MAG, SGMS1 | HTR2C 4581/4885MEN1 3605/4885KMT2A 2028/4885 |
| US-20190269670-A1 | COMPOUNDS AND METHODS OF PROMOTING MYELINATION | GMFG, MAG, SGMS1 | HTR2C 4581/4885MEN1 3605/4885KMT2A 2028/4885 |
| US-20170349607-A1 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | BRD4, BRD3, BRDT | HTR2C 3194/4885MEN1 3579/4885KMT2A 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.